Delivery Order SPE2DB24D1104-SPE2DB25FXUH6
Award Date
11/6/24
Potential Completion Date
11/7/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,569.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the procurement of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product, for an...
This federal contract award, with an ID of SPE2DB22D3004|SPE2DB25FNV19, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,118.66 firm fixed-price delivery order is for the supply of 4566713949 - APREPITANT 40 MG CAPSULE UD 5S. The contract has an ultimate completion date of December 16, 2024 and was awarded on December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $4,162.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product, with a performance period extending through April 2025. The contract is a delivery order and is priced on a firm-fixed-price basis. It is not designated as a set-aside contract, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,219.21 firm fixed-price delivery order is for APREPITANT 80 MG CAPSULE UD 6S, with a period of performance through January 15, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of APREPITANT 40 MG CAPSULE UDS. The contract is a Delivery Order with a Firm Fixed Price of $1,984.41 and a period of performance through June 25, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, on June 24, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract, awarded by the Defense Logistics Agency (DLA), is for the provision of 4564445711 - APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $3,954.22 and has an ultimate completion date of May 1, 2024. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $7,008.15, with a Firm Fixed Price pricing type. The award is for the provision of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product. The contract has an Ultimate Completion Date of June 12, 2025. Amerisourcebergen Drug Corp is the prime contractor on this award, which is...
This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6PDN, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,186.78 firm fixed-price Delivery Order is for the supply of 4564978529 APREPITANT 80 MG CAPSULE UD 6S. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,213.68, is for the supply of 4,568,175,168 units of the medication Aprepitant 40 mg capsules. The award does not have a set-aside designation, indicating open competition. The contract has a period of performance through May 8, 2025. AmerisourceBergen also holds a larger $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,379.24 firm fixed-price delivery order is for 24,000 units of a 100-count capsule product, with a completion date of May 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...